BIPH:NYE-Safeplus International Holdings Limited (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 16.67

Change

-0.09 (-0.54)%

Market Cap

USD 0.36M

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Biophan Technologies, Inc. develops and markets various technologies for the medical device industries. The company is seeking partners to monetize its patented technologies, including biothermal power supply and pulsewidth modulation technology to enhance the performance of pacemakers and neurostimulators, and photonics and nanomaterials patents. The company was founded in 1963 and is based in Pittsford, New York.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-26 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

+1.17 (+0.52%)

USD 66.03B
ALC Alcon AG

+0.22 (+0.26%)

USD 41.92B
RMD ResMed Inc

+1.30 (+0.56%)

USD 34.83B
BAX Baxter International Inc

+0.22 (+0.76%)

USD 16.24B
AVTR Avantor Inc

+0.12 (+0.56%)

USD 14.44B
ATR AptarGroup Inc

-0.50 (-0.31%)

USD 11.39B
TFX Teleflex Incorporated

+2.88 (+1.62%)

USD 8.27B
BLCO Bausch + Lomb Corp

+0.28 (+1.57%)

USD 7.27B
STVN Stevanato Group SpA

+0.74 (+3.52%)

USD 6.36B
WRBY Warby Parker Inc

-0.69 (-2.68%)

USD 2.84B

ETFs Containing BIPH

ABEQ Absolute Core Strategy ET.. 6.91 % 0.00 %

+0.06 (+0.61%)

USD 0.09B
XEYX:XETRA BNP Paribas Easy CAC 40®.. 5.72 % 0.00 %

N/A

USD 0.32B
C40:SW Amundi Index Solutions - .. 5.14 % 0.00 %

N/A

N/A
C4DE:SW Amundi Index Solutions - .. 5.14 % 0.00 %

N/A

N/A
UFO Procure Space ETF 4.92 % 0.00 %

+0.75 (+0.61%)

USD 0.05B
ASWC:XETRA HANetf ICAV - Future of D.. 4.90 % 0.00 %

N/A

USD 0.65B
STQX:SW SPDR® MSCI Europe Indust.. 4.52 % 0.00 %

N/A

USD 0.48B
DEMZ Democratic Large Cap Core.. 4.32 % 0.00 %

+0.13 (+0.61%)

USD 0.04B
NATO Themes Transatlantic Defe.. 4.31 % 0.00 %

+0.16 (+0.61%)

USD 1.56M
PJIO PGIM ETF Trust 4.14 % 0.00 %

+0.11 (+0.61%)

USD 0.01B
CGGO Capital Group Global Grow.. 2.73 % 0.00 %

-0.14 (0.61%)

USD 4.90B
C50U:LSE Amundi Index Solutions - .. 2.45 % 0.00 %

N/A

USD 0.02B
CGGE Capital Group Global Equi.. 1.94 % 0.00 %

+0.02 (+0.61%)

USD 0.08B
FITE SPDR S&P Kensho Future Se.. 1.73 % 0.20 %

+1.19 (+0.61%)

USD 0.09B
SPVM Invesco S&P 500 Value wit.. 1.68 % 0.39 %

+0.19 (+0.61%)

USD 0.09B
ULVM VictoryShares US Value Mo.. 1.32 % 0.20 %

+0.18 (+0.61%)

USD 0.15B
ALTL Pacer Lunt Large Cap Alte.. 1.18 % 0.00 %

+0.02 (+0.61%)

USD 0.19B
XRLV Invesco S&P 500® ex-Rate.. 1.17 % 0.25 %

+0.04 (+0.61%)

N/A
LOWV:LSE SPDR® S&P 500 Low Volati.. 1.15 % 0.00 %

N/A

N/A
USLV:LSE SPDR® S&P 500 Low Volati.. 1.15 % 0.00 %

N/A

USD 0.13B
SPY1:F SSgA SPDR ETFs Europe I P.. 1.15 % 0.00 %

N/A

N/A
SPY1:XETRA SPDR® S&P 500 Low Volati.. 1.15 % 0.00 %

N/A

USD 0.13B
UC95:LSE UBS (Irl) ETF plc - Facto.. 0.78 % 0.00 %

N/A

USD 0.04B
UBUR:F UBS (Irl) ETF Public Limi.. 0.77 % 0.00 %

N/A

USD 0.04B
UBUV:F UBS (Irl) ETF Public Limi.. 0.77 % 0.00 %

N/A

USD 4.42M
UBUR:XETRA UBS (Irl) ETF plc - Facto.. 0.77 % 0.00 %

N/A

USD 0.04B
UBUV:XETRA UBS (Irl) ETF plc - Facto.. 0.77 % 0.00 %

N/A

USD 9.08M
CFO VictoryShares US 500 Enha.. 0.33 % 0.35 %

+0.05 (+0.61%)

USD 0.46B
EWQ iShares MSCI France ETF 0.00 % 0.47 %

+0.15 (+0.61%)

N/A
VAMO Cambria Value and Momentu.. 0.00 % 0.64 %

+0.13 (+0.61%)

N/A
ISFR:LSE iShares MSCI France UCITS 0.00 % 0.00 %

N/A

USD 0.18B
NDUS:LSE SPDR® MSCI Europe Indust.. 0.00 % 0.00 %

N/A

N/A
C40:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.82B
CAC:PA Amundi CAC 40 UCITS ETF D.. 0.00 % 0.00 %

N/A

USD 3.13B
CACC:PA Lyxor CAC 40 (DR) UCITS E.. 0.00 % 0.00 %

N/A

USD 0.63B
E40:PA BNP Paribas Easy CAC 40®.. 0.00 % 0.00 %

N/A

USD 0.21B
GWT:PA Amundi MSCI Europe Growth.. 0.00 % 0.00 %

N/A

USD 0.08B
STQ:PA SPDR® MSCI Europe Indust.. 0.00 % 0.00 %

N/A

USD 0.48B
EXH4:F iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

N/A
GC40:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
IQQG:F iShares Public Limited Co.. 0.00 % 0.00 %

N/A

N/A
IS3U:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
LGWT:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

N/A

N/A
SPYQ:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

N/A
EL4C:XETRA Deka STOXX Europe Strong .. 0.00 % 0.00 %

N/A

USD 0.29B
EL4E:XETRA Deka STOXX Europe Strong .. 0.00 % 0.00 %

N/A

USD 0.04B
DX2G:XETRA Xtrackers - CAC 40 UCITS .. 0.00 % 0.00 %

N/A

USD 0.12B
EXH4:XETRA iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

USD 0.16B
GC40:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.91B
IQQG:XETRA iShares EURO Total Market.. 0.00 % 0.00 %

N/A

USD 0.29B
IS3U:XETRA iShares MSCI France UCITS 0.00 % 0.00 %

N/A

USD 0.11B
LGWT:XETRA Amundi MSCI Europe Growth.. 0.00 % 0.00 %

N/A

USD 0.20B
SPYQ:XETRA SPDR® MSCI Europe Indust.. 0.00 % 0.00 %

N/A

USD 0.31B
JIG JPMorgan International Gr.. 0.00 % 0.00 %

+0.07 (+0.61%)

USD 0.12B
C4D:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.12B
DXIF:CA Dynamic Active Internatio.. 0.00 % 0.00 %

N/A

CAD 6.39M
ESIN:LSE iShares MSCI Europe Indus.. 0.00 % 0.00 %

N/A

USD 0.34B
ESIN:F iShares MSCI Europe Indus.. 0.00 % 0.00 %

N/A

USD 0.32B
ESIN:XETRA iShares MSCI Europe Indus.. 0.00 % 0.00 %

N/A

USD 0.16B
AVSD American Century ETF Trus.. 0.00 % 0.00 %

+0.36 (+0.61%)

USD 0.15B

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.66% 58% F 35% F
Dividend Return 7.46% 100% F 84% B
Total Return 6.80% 63% D 46% F
Trailing 12 Months  
Capital Gain -1.01% 58% F 35% F
Dividend Return 7.43% 100% F 84% B
Total Return 6.42% 58% F 46% F
Trailing 5 Years  
Capital Gain 5,109.38% 100% F 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5,109.38% 100% F 100% F
Average Annual (5 Year Horizon)  
Capital Gain 72,058.17% 100% F 100% F
Dividend Return 72,060.87% 100% F 100% F
Total Return 2.71% 100% F 60% D-
Risk Return Profile  
Volatility (Standard Deviation) N/A 5% F N/A F
Risk Adjusted Return 31.01% 84% B 45% F
Market Capitalization 0.36M 7% C- N/A F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.